EGFR and adenocarcinoma: There was no evidence of differences in age (P= .915), smoking status (P = .047), lymph node involvement(P = .124), early-stage adenocarcinoma (P= .056), or EGFR mutation (P = .676) betweenthe two groups (Table 3).